Analysed ABIVAX SA-ADR (ABVX:NASDAQ) News Sources
Valerio Therapeutics Announces Development Collaboration with Abivax and Provides Pipeline Update
16-07-2026
yahoo.com
Abivax Strengthens Commercial Capabilities With Strategic Leadership Appointments
23-07-2026
yahoo.com
ABIVAX Société Anonyme (ENXTPA:ABVX) Adds Commercial Leaders, Is The Upside Already Priced In?
26-07-2026
yahoo.com
Evexta Bio Announces Clinical Trial Collaboration and Supply Agreement with Roche to Evaluate Rupitasertib in Combination with a Selective Estrogen Receptor Degrader in Advanced / Metastatic Breast Cancer
04-08-2026
yahoo.com
PK MED Strengthens Its Strategic and Scientific Governance to Support the Development of Its Therapeutic Micro-implants
29-07-2026
yahoo.com
Inflammatory Bowel Disease Market to Experience Strong Uptake During the Forecast Period (2026-2036), Driven by Development of Next-generation Therapies Targeting IL-23, TL1A, and S1P Pathways | DelveInsight
30-07-2026
yahoo.com
Ulcerative Colitis Market Outlook: 5 Late-Stage Drug Candidates to Watch | DelveInsight
07-09-2026
yahoo.com
What is the current price of ABIVAX SA-ADR (ABVX:NASDAQ)?
The current price of ABIVAX SA-ADR (ABVX:NASDAQ) is $118.64.
ABIVAX SA-ADR (ABVX:NASDAQ) absolute price change since previous trading day?
The absolute price change of ABIVAX SA-ADR (ABVX:NASDAQ) since the previous trading day is $2.69.
ABIVAX SA-ADR (ABVX:NASDAQ) percentage price change since previous trading day?
The percentage price change of ABIVAX SA-ADR (ABVX:NASDAQ) since the previous trading day is 2.32%.
What is the most recent average sentiment score for ABIVAX SA-ADR (ABVX:NASDAQ)?
The most recent average sentiment score for ABIVAX SA-ADR (ABVX:NASDAQ) is 79 out of 100.
What is the most recent average sentiment for ABIVAX SA-ADR (ABVX:NASDAQ)?
The most recent sentiment for ABIVAX SA-ADR (ABVX:NASDAQ) is .
SEC-8K** Filing Available For ABIVAX SA-ADR (ABVX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.